Factor VIII inhibitors in hemophilia A treated with emicizumab
Por um escritor misterioso
Descrição

Use of chromogenic Factor VIII activity determination in

A bispecific antibody to factors IXa and X restores factor VIII

JCM, Free Full-Text

Emicizumab for the treatment of acquired hemophilia A - ScienceDirect

Emicizumab and the Clinical Coagulation Laboratory

Diagnostics, Free Full-Text
Emicizumab Prophylaxis in Hemophilia A

A new standard of care in hemophilia A?

Pharmaceuticals, Free Full-Text

The role of emicizumab, a bispecific factor IXa- and factor X
de
por adulto (o preço varia de acordo com o tamanho do grupo)